Open Access. Powered by Scholars. Published by Universities.®
Medicinal and Pharmaceutical Chemistry Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Chemicals and Drugs (9)
- Other Pharmacy and Pharmaceutical Sciences (8)
- Pharmaceutics and Drug Design (7)
- Chemistry (4)
- Life Sciences (4)
-
- Physical Sciences and Mathematics (4)
- Medical Sciences (3)
- Medicinal-Pharmaceutical Chemistry (3)
- Pharmaceutical Preparations (3)
- Amino Acids, Peptides, and Proteins (2)
- Animal Experimentation and Research (2)
- Chemical and Pharmacologic Phenomena (2)
- Diseases (2)
- Lipids (2)
- Medical Biochemistry (2)
- Medical Pharmacology (2)
- Medical Specialties (2)
- Nanomedicine (2)
- Nanotechnology (2)
- Natural Products Chemistry and Pharmacognosy (2)
- Nursing (2)
- Oncology (2)
- Organic Chemistry (2)
- Research Methods in Life Sciences (2)
- Alternative and Complementary Medicine (1)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Biochemistry, Biophysics, and Structural Biology (1)
- Institution
-
- Chapman University (9)
- Marshall University (2)
- Purdue University (2)
- University of Tennessee Health Science Center (2)
- Virginia Commonwealth University (2)
-
- Butler University (1)
- Cleveland State University (1)
- Columbus State University (1)
- East Tennessee State University (1)
- Loma Linda University (1)
- Parkland College (1)
- Portland State University (1)
- Southern Adventist University (1)
- University of Connecticut (1)
- University of Kentucky (1)
- University of New Orleans (1)
- University of North Florida (1)
- University of Rhode Island (1)
- Western Michigan University (1)
- Keyword
-
- 1 (1)
- 10-Diones (1)
- 14‐helical structure (1)
- 4- and 9 (1)
- Academic -- UNF -- Doctor of Nursing Practice; Dissertations (1)
-
- Academic -- UNF -- Nursing; DNP; D.N.P.; cannabis; marijuana; chronic pain; neuropathic pain; Marijuana -- Therapeutic use -- Effectiveness -- Statistics; Cannabis -- Therapeutic use -- Effectiveness -- Statistics; Chronic pain -- Alternative treatment; Chronic pain -- Prevention (1)
- Activity (1)
- Addiction Pharmacotherapy (1)
- Antifolate (1)
- Antimalarials -- Development (1)
- Antiproliferative activity (1)
- Apoptosis (1)
- Apurinic/apyrimidinic endonuclease- 1/redox effector factor 1 (1)
- Astrocytes (1)
- Brain (1)
- CB1 Receptor (1)
- CRIP1a (1)
- Cancer (1)
- Candida (1)
- Cannabinoid Receptor (1)
- Cells (1)
- Chemotheraphy (1)
- Chemotherapy (1)
- Chloroquine (1)
- Copper (1)
- Crystallization (1)
- Crystallography (1)
- Dexamethasone (1)
- Diastereoselective synthesis (1)
- Dihydrofolate Reductase (1)
- Publication
-
- Pharmacy Faculty Articles and Research (9)
- Theses and Dissertations (3)
- Pharmaceutical Science and Research (2)
- Theses and Dissertations (ETD) (2)
- Borch Department of Medicinal Chemistry and Molecular Pharmacology Faculty Publications (1)
-
- Dissertations (1)
- Dissertations and Theses (1)
- Faculty Works (1)
- Graduate Thesis Collection (1)
- Honors Scholar Theses (1)
- Loma Linda University Electronic Theses, Dissertations & Projects (1)
- Natural Sciences Student Research Presentations (1)
- Senior Honors Projects (1)
- The Summer Undergraduate Research Fellowship (SURF) Symposium (1)
- Theses and Dissertations--Pharmacy (1)
- UNF Graduate Theses and Dissertations (1)
- Undergraduate Honors Theses (1)
- Undergraduate Research Posters 2014 (1)
- University of New Orleans Theses and Dissertations (1)
- Publication Type
Articles 31 - 31 of 31
Full-Text Articles in Medicinal and Pharmaceutical Chemistry
Beta-Blockers Act Through Clathrin-Dependent Internalization And Egfr Transactivation To Promote Erk Phosphorylation, Taiwo Ajumobi
Beta-Blockers Act Through Clathrin-Dependent Internalization And Egfr Transactivation To Promote Erk Phosphorylation, Taiwo Ajumobi
Graduate Thesis Collection
For cardiovascular diseases such as high blood pressure, angina pectoris, and left ventricle hypertrophy; long-term activation of beta-adrenergic receptors is strongly linked to the progression of these diseases. A class of antagonistic drugs that target betaadrenergic receptors are collectively called beta-blockers. These drugs are commonly used to reduce the inotropic and chronotropic effects of beta-adrenergic receptor activation. This past decade has revealed that beta-blockers and other ligands are capable of functional selectivity at receptors. Functional selectivity describes the ability of ligands acting at 0 protein-coupled receptors (OPCRs) to preferentially activate or inhibit different signal transduction pathways. The studies on beta-adrenergic …